Cargando…
A Novel Promoter CpG-Based Signature for Long-Term Survival Prediction of Breast Cancer Patients
DNA methylation has been reported as one of the most critical epigenetic aberrations during the tumorigenesis and development of breast cancer (BC). This study explored a novel promoter CpG-based signature for long-term survival prediction of BC patients. We used The Cancer Genome Atlas (TCGA) data...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606941/ https://www.ncbi.nlm.nih.gov/pubmed/33194705 http://dx.doi.org/10.3389/fonc.2020.579692 |